Company Filing History:
Years Active: 2022-2025
Title: Christian Hess: Innovator in Antibody Development
Introduction
Christian Hess is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 8 patents to his name, Hess has established himself as a key figure in the advancement of therapeutic solutions.
Latest Patents
Among his latest patents is an invention titled "Antibodies targeting CD137 and methods of use thereof." This invention relates to an isolated antibody that specifically binds to human CD137, along with pharmaceutical compositions and methods of use. Additionally, he has developed a patent for a "Multispecific antibody comprising CD137 binding domain and PDL1 binding domain." This invention includes a multispecific antibody that contains at least one CD137 binding domain and one PDL1 binding domain, along with related nucleic acids and methods for production.
Career Highlights
Christian Hess has worked with notable companies in the biotechnology sector, including Numab Therapeutics AG and Namab Therapeutics AG. His work in these organizations has contributed to the development of cutting-edge therapeutic antibodies.
Collaborations
Some of his coworkers include Tea Gunde and Alexandre Simonin, who have collaborated with him on various projects in the field of antibody research.
Conclusion
Christian Hess is a distinguished inventor whose work in antibody development has the potential to impact therapeutic applications significantly. His innovative patents and collaborations highlight his commitment to advancing biotechnology.